These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1883690)

  • 21. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects.
    Setty AR; Sigal LH
    Semin Arthritis Rheum; 2005 Jun; 34(6):773-84. PubMed ID: 15942912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study.
    Mielants H; Veys EM; Van der Straeten C; Ackerman C; Goemaere S
    J Rheumatol; 1991 Jul; 18(7):978-83. PubMed ID: 1920332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse events in methotrexate-treated rheumatoid arthritis patients.
    Sandoval DM; Alarcón GS; Morgan SL
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():49-56. PubMed ID: 8535650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate: its use in the rheumatic diseases.
    Bookbinder SA; Espinoza LR; Fenske NA; Germain BF; Vasey FB
    Clin Exp Rheumatol; 1984; 2(2):185-93. PubMed ID: 6398173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience with long term low dose methotrexate treatment in rheumatoid arthritis and arthritic psoriasis].
    Náfrádi L; Varga L
    Orv Hetil; 1995 Jul; 136(29):1555-7. PubMed ID: 7637973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate in the treatment of rheumatoid arthritis.
    Korn S; Dehoratius RJ
    Am Fam Physician; 1989 Oct; 40(4):243-6. PubMed ID: 2679014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low dose methotrexate in rheumatoid arthritis.
    Steinsson K; Weinstein A; Korn J; Abeles M
    J Rheumatol; 1982; 9(6):860-6. PubMed ID: 7161777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver toxicity does not have to follow methotrexate therapy of patients with rheumatoid arthritis.
    Kremer JM
    Am J Gastroenterol; 1997 Feb; 92(2):194-6. PubMed ID: 9040190
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacokinetics of methotrexate in rheumatoid arthritis: therapeutic implications].
    Bannwarth B; Péhourcq F; Lequen L
    Therapie; 1997; 52(2):129-32. PubMed ID: 9231507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methotrexate in rheumatoid polyarthritis. Review of the literature].
    Sauvezie B; Dubost JJ; Garandeau A; Rampon S
    Rev Rhum Mal Osteoartic; 1987; 54(7-9):607-15. PubMed ID: 3313672
    [No Abstract]   [Full Text] [Related]  

  • 31. Methotrexate: first-line or second-line immunomodulator?
    Fraser AG
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):225-31. PubMed ID: 12610315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Incidence of acral nodulosis with long-term methotrexate therapy in patients with inflammatory rheumatic diseases].
    Wagener P
    Z Rheumatol; 1994; 53(6):346-50. PubMed ID: 7871907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Low-dose methotrexate therapy of rheumatoid arthritis in the elderly].
    Schmidt Z; Szilágyi M; Megyeri A; Merétey K
    Orv Hetil; 1995 May; 136(22):1157-61. PubMed ID: 7761078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
    Weinblatt ME; Kremer JM; Coblyn JS; Maier AL; Helfgott SM; Morrell M; Byrne VM; Kaymakcian MV; Strand V
    Arthritis Rheum; 1999 Jul; 42(7):1322-8. PubMed ID: 10403258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methotrexate and non-steroidal anti-inflammatory agent combination in rheumatoid arthritis].
    Bertin P; Carpentier N; Vergne P; Bonnet C; Bannwarth B; Dehais J; Treves R
    Therapie; 1997; 52(2):133-7. PubMed ID: 9231508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methotrexate in rheumatology].
    Sany J
    Rev Rhum Ed Fr; 1993; 60(7-8):481-4. PubMed ID: 8148846
    [No Abstract]   [Full Text] [Related]  

  • 37. Methotrexate-associated, early-onset pancytopenia in rheumatoid arthritis.
    Doolittle GC; Simpson KM; Lindsley HB
    Arch Intern Med; 1989 Jun; 149(6):1430-1. PubMed ID: 2730263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe pancytopenia in a patient taking low dose methotrexate and probenecid.
    Basin KS; Escalante A; Beardmore TD
    J Rheumatol; 1991 Apr; 18(4):609-10. PubMed ID: 2066953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response.
    Breedveld F; Agarwal S; Yin M; Ren S; Li NF; Shaw TM; Davies BE
    J Clin Pharmacol; 2007 Sep; 47(9):1119-28. PubMed ID: 17766699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and design.
    Hillson JL; Furst DE
    Rheum Dis Clin North Am; 1997 Nov; 23(4):757-78. PubMed ID: 9361154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.